Skip to main content

Table 5 Embryological outcomes of ICSI cycles

From: Effects of SARS-CoV-2 infection on embryological outcomes in assisted reproductive technology during the Omicron epidemic

 

COVID-19 (n = 10)

Non COVID-19 (n = 59)

X2

P value

Oocyte maturity rate (%)

65.79 (75/114)

74.29 (552/743)

3.640

0.056

Fertilization rate (%)

74.66 (56/75)

80.8 (446/552)

1.555

0.212

2PN rate (%)

65.33 (49/75)

71.74 (396/552)

1.315

0.251

D3 available embryos rate (%)

42.86 (24/56)

50.45 (224/444)

1.147

0.284

D3 good-quality embryos rate (%)

16.33 (8/49)

24.81 (98/395)

1.726

0.189

Blastocyst formation rate (%)

35.48 (11/31)

45.77 (146/319)

1.208

0.272

Good-quality blastocyst formation rate (%)

12.9 (4/31)

22.57 (72/319)

1.553

0.213

  1. ICSI, intracytoplasmic sperm injection; COVID-19, Coronavirus disease-2019; 2PN, 2 pronucleus; D3, day 3